EODData

MEMBERSHIP REGISTER LOG IN

NASDAQ, BCRX: Biocryst Pharma Inc

14 Aug 26 15:59
LAST:

9.745

CHANGE:
 0.07		OPEN:
9.800		HIGH:
9.900		ASK:
4.360		VOLUME:
2.74M
CHG(%):
0.71		PREV:
9.810		LOW:
9.460		BID:
10.120		 

CHART

RECENT END OF DAY PRICES

DateOpenHighLowCloseVolume
14 Aug 269.6809.8009.4609.7403.82M
13 Aug 2610.59010.6309.7009.8104.58M
12 Aug 2610.33010.68010.10010.5903.87M
11 Aug 269.86010.5909.78010.3405.03M
10 Aug 269.3309.8559.2809.8404.02M
07 Aug 269.5009.6659.2309.3804.38M
06 Aug 269.0409.5308.9809.3004.04M
05 Aug 269.4409.6708.8059.0706.09M
04 Aug 268.8209.0408.7609.0202.92M
03 Aug 269.0009.0758.7708.8103.19M

PROFILE

Name:Biocryst Pharma Inc
About:BioCryst Pharmaceuticals, Inc., a biotechnology company, develops oral small-molecule and injectable protein therapeutics to treat rare diseases. The company markets peramivir injection, an intravenous neuraminidase inhibitor for the treatment of acute uncomplicated influenza under the RAPIVAB, RAPIACTA, and PERAMIFLU names; and ORLADEYO, an oral serine protease inhibitor to treat hereditary angioedema. It is also developing BCX17725, a protein therapeutic for netherton syndrome which is in phase 1; Avoralstat, an ocular plasma kallikrein inhibitor for diabetic macular edema that is in preclinical phase; and BCX10013, an oral Factor D inhibitor for complement-mediated diseases, as well as developing Oral C5 Inhibitor and Oral C2 Inhibitor. The company has collaborations and in-license relationships with the Torii Pharmaceutical Co., Shionogi & Co., Ltd., Green Cross Corporation; National Institute of Allergy and Infectious Diseases; Biomedical Advanced Research and Development Authority; the U.S. Department of Health and Human Services; and The University of Alabama at Birmingham, as well as Albert Einstein College of Medicine of Yeshiva University and Industrial Research, Ltd. BioCryst Pharmaceuticals, Inc. was founded in 1986 and is headquartered in Durham, North Carolina.
Sector:Healthcare
Address:4505 Emperor Boulevard, Durham, NC, United States, 27703
Website:https://www.biocryst.com
CUSIP:09058V103
CIK:0000882796
ISIN:US09058V1035
FIGI:BBG000BLYWX6
LEI:549300Z0INP1Z5NP6J59

API SERVICE  NEW

Have you tried our new API Service yet?

For more information, visit our API page.

You can get your ApiKey over HERE.

If you're ready to get going, then jump over to:
https://api.eoddata.com

SYMBOL HISTORY

   Add to Watchlist

DOWNLOAD DATA

Download stock quote history quickly and easily in a variety of formats to suit your needs.

  Download

FUNDAMENTALS

Trailing P/E:7.83 
Forward P/E:14.96 
PEG Ratio:0.12 
Price to Sales:2.76 
Price to Book:-4.67 
Profit Margin:-0.06 
Operating Margin:0.18 
Return on Assets:0.07 
Return on Equity:0.19 
EPS Ratio:-1.77 
Revenue:557.51M 
EBITDA:13.45M 
Shares:254.16M 
Market Cap:2.477B 

TECHNICAL INDICATORS

MA5:10.063.3%
MA10:9.591.6%
MA20:9.492.7%
MA50:9.463.0%
MA100:9.285.0%
MA200:8.3716.5%
STO9:43.37
STO14:49.73
RSI14:52.09
WPR14:-47.75
ATR:0.50 
Week High:10.689.6%
Week Low:9.235.6%
Month High:10.689.6%
Month Low:8.7616.5%
Year High:11.2215.1%
Year Low:6.0062.4%
Volatility:24.13 

RECENT DIVIDENDS

Date Amount
11 Jun 2014$0.00
05 Jun 2014$0.00
20 May 2014$0.00
16 May 2014$0.00
02 Apr 2014$0.00